Guaraldi Federica, Karamouzis Ioannis, Berardelli Rita, D'Angelo Valentina, Rampino Alessia, Zichi Clizia, Ghigo Ezio, Giordano Roberta
Front Horm Res. 2016;46:159-70. doi: 10.1159/000443915. Epub 2016 May 17.
Adrenal failure secondary to hypothalamic-pituitary disease is a common although underestimated and underdiagnosed condition, with serious consequences. Corticotropin deficiency can be isolated or more frequently occur in association with other pituitary hormones deficiencies. The most frequent endogenous cause of secondary adrenal insufficiency (SAI) is a tumor of the hypothalamic-pituitary region, usually associated with panhypopituitarism secondary to tumor growth or to its treatment with surgery or irradiation. Less commonly, SAI is due to nontumoral disorders including infiltrative lesions, infective processes, vascular alterations, traumatic brain injury, empty sella or genetic disorders. Finally, long-term administration of exogenous glucocorticoids can determine secondary and/or tertiary hypoadrenalism acting at the hypothalamic level and leading to prolonged suppression of the hypothalamic-pituitary-adrenal axis. It is essential to perform validated diagnostic procedures in order to promptly diagnose hypoadrenalism so as to prevent an adrenal crisis. At the same time, diagnosis is complex as no single test has sufficient sensitivity to identify all patients with SAI. Therefore, clinical judgment and follow-up are crucial for the assessment of corticotropin deficiency. Patients with persisting suggestive symptoms and/or a clinical history of higher risk for adrenal insufficiency deserve careful subsequent reassessments.
继发于下丘脑 - 垂体疾病的肾上腺功能衰竭是一种常见但被低估和诊断不足的疾病,会产生严重后果。促肾上腺皮质激素缺乏可能是孤立的,或更常见的是与其他垂体激素缺乏同时出现。继发性肾上腺皮质功能减退(SAI)最常见的内源性病因是下丘脑 - 垂体区域的肿瘤,通常与肿瘤生长或手术、放疗治疗导致的全垂体功能减退有关。较少见的情况下,SAI 是由非肿瘤性疾病引起的,包括浸润性病变、感染性疾病、血管改变、创伤性脑损伤、空蝶鞍或遗传性疾病。最后,长期使用外源性糖皮质激素可导致继发性和 / 或三级肾上腺功能减退,作用于下丘脑水平,导致下丘脑 - 垂体 -肾上腺轴长期受抑制。为了及时诊断肾上腺功能减退以预防肾上腺危象,进行经过验证的诊断程序至关重要。同时,诊断很复杂,因为没有单一测试具有足够的敏感性来识别所有 SAI 患者。因此,临床判断和随访对于评估促肾上腺皮质激素缺乏至关重要。有持续提示症状和 / 或肾上腺功能不全高风险临床病史的患者值得仔细的后续重新评估。